martes, 23 de octubre de 2018

Santhera's Potential CF Inhalation Therapy Favored for Orphan Drug Status in EU

Santhera's Potential CF Inhalation Therapy Favored for Orphan Drug Status in EU

Cystic Fibrosis News Today



Santhera’s Potential CF Inhalation Therapy Favored for Orphan Drug Status in EU

No hay comentarios:

Publicar un comentario